Clinical Trial Update: Donepezil Attenuate Postoperative Cognitive Dysfunction [Phase 3]

View source ↗

Summary

Phase 3 trial update exploring donepezil to attenuate postoperative cognitive dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoral Head Necrosis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: RenJi Hospital | Conditions: Osteoarthritis, Femoral Head Necrosis | Phase 3 | Status: UNKNOWN